UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

Seminars in immunopathology, 2011-07, Vol.33 (4), p.369-383

2011

Volltextzugriff (PDF)

Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy

Frontiers in immunology, 2020-10, Vol.11, p.582744-582744

2020

Volltextzugriff (PDF)

Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma

Journal of investigative dermatology, 2017-01, Vol.137 (1), p.159-169

2017

Volltextzugriff (PDF)

Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration

Clinical cancer research, 2007-01, Vol.13 (2), p.644-653

2007

Volltextzugriff (PDF)

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

Trials, 2021-09, Vol.22 (1), p.584-584, Article 584

2021

Volltextzugriff (PDF)

Type I IFN regulate DC turnover in vivo

European journal of immunology, 2009-07, Vol.39 (7), p.1807-1818

2009

Volltextzugriff (PDF)

The role of exosomes in colorectal cancer disease progression and response to therapy

Cytokine & growth factor reviews, 2020-02, Vol.51, p.84-91

2020

Volltextzugriff (PDF)

Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade

Cells (Basel, Switzerland), 2020-04, Vol.9 (4), p.940

2020

Volltextzugriff (PDF)

Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model

The Journal of immunology (1950), 2002-07, Vol.169 (1), p.375-383

2002

Volltextzugriff (PDF)

Immunomodulatory properties of CNF1 toxin from E. coli : implications for colorectal carcinogenesis

American journal of cancer research, 2022-01, Vol.12 (2), p.651-660

2022

Volltextzugriff (PDF)

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

Cells (Basel, Switzerland), 2021-04, Vol.10 (4), p.845

2021

Volltextzugriff (PDF)

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level

Vaccine, 2005-04, Vol.23 (23), p.2994-3004

2005

Volltextzugriff (PDF)

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Cytokine & growth factor reviews, 2020-08, Vol.54, p.43-50

2020

Volltextzugriff (PDF)

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (3), p.768-778

2011

Volltextzugriff (PDF)

The added value of type i interferons to cytotoxic treatments of cancer

Cytokine & growth factor reviews, 2017-08, Vol.36, p.89-97

2017

Volltextzugriff (PDF)

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Nature Medicine, 2014-11, Vol.20 (11), p.1301-1309

2014

Volltextzugriff (PDF)

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Nature immunology, 2022-09, Vol.23 (9), p.1379-1392

2022

Volltextzugriff (PDF)

Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19

Cytokine & growth factor reviews, 2022-02, Vol.63, p.23-33

2022

Volltextzugriff (PDF)

Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies

Cancers, 2021-09, Vol.13 (18), p.4499

2021

Volltextzugriff (PDF)

Consensus guidelines for the detection of immunogenic cell death

Oncoimmunology, 2014-10, Vol.3 (9), p.e955691

2014

Volltextzugriff (PDF)

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming

The Journal of immunology (1950), 2011-05, Vol.186 (9), p.5142-5150

2011

Volltextzugriff (PDF)

Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A0201+ BKV-seropositive donors

Journal of translational medicine, 2006-11, Vol.4 (1), p.47-47, Article 47

2006

Volltextzugriff (PDF)

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Nature immunology, 2024-11, Vol.25 (11), p.2166-2166

2024

Volltextzugriff (PDF)

Clinical applications of virosomes in cancer immunotherapy

Expert opinion on biological therapy, 2006-11, Vol.6 (11), p.1113-1121

2006

Volltextzugriff (PDF)

Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models

Methods in enzymology, 2020, Vol.632, p.457-477

2020

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Englisch
(157)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy

Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma

Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration

Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

Type I IFN regulate DC turnover in vivo

The role of exosomes in colorectal cancer disease progression and response to therapy

Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade

Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model

Immunomodulatory properties of CNF1 toxin from E. coli : implications for colorectal carcinogenesis

Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

The added value of type i interferons to cytotoxic treatments of cancer

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19

Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies

Consensus guidelines for the detection of immunogenic cell death

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming

Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A0201+ BKV-seropositive donors

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Clinical applications of virosomes in cancer immunotherapy

Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models

Suchergebnisse filtern